ATP-binding site of bacterial enzymes as a target for antibacterial drug design

Journal of Medicinal Chemistry

Volumn 54, Issue 4, 2011, Pages 915-929

  Škedelj, Veronika ^a   Tomašić, Tihomir ^a   Mašič, Lucija Peterlin ^a   Zega, Anamarija ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

6,7 DICHLORO 2,3 DIHYDRO 5 (N,N DIMETHYLSULFAMOYL)COUMARILIC ACID; ADENOSINE TRIPHOSPHATE; ANTIINFECTIVE AGENT; BACTERIAL ENZYME; BENZIMIDAZOLE; COUMAMYCIN A1; INDAZOLE DERIVATIVE; NATURAL PRODUCT; NOVOBIOCIN; PROTEIN KINASE INHIBITOR; RADICICOL;

ARTICLE; BINDING SITE; COMPETITIVE INHIBITION; DRUG DESIGN; DRUG TARGETING; HIGH THROUGHPUT SCREENING; HUMAN; NONHUMAN;

ADENOSINE TRIPHOSPHATE; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BACTERIAL PROTEINS; DRUG DESIGN; HUMANS; MODELS, MOLECULAR; MOLECULAR TARGETED THERAPY;

EID: 79951818072     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm101121s     Document Type: Article

References (86)

1. Boucher, H. W.; Talbot, G. H.; Bradley, J. S.; Edwards, J. E., Jr.; Gilbert, D.; Rice, L. B.; Scheld, M.; Spellberg, B.; Bartlett, J. Bad bugs, no drugs: NO ESKAPE! An update from the Infectious Diseases Society of America Clin. Infect. Dis. 2009, 48, 1-12
2. The Bacterial Challenge: Time to React; Technical Report EMEA/576176/2009; EMEA: London, 2009.
3. Jones, D. The antibacterial lead discovery challenge Nat. Rev. Drug Discovery 2010, 9, 751-752
4. Thomson, C. J.; Power, E.; Ruebsamen-Waigmann, H.; Labischinski, H. Antibacterial research and development in the 21st century-an industry perspective of the challenges Curr. Opin. Microbiol. 2004, 7, 445-450 (Pubitemid 39297123)
5. Shlaes, D. M. An update on tetracyclines Curr. Opin. Invest. Drugs 2006, 7, 167-171 (Pubitemid 43230913)
6. Payne, D. J.; Gwynn, M. N.; Holmes, D. J.; Pompliano, D. L. Drugs for bad bugs: confronting the challenges of antibacterial discovery Nat. Rev. Drug Discovery 2007, 6, 29-40 (Pubitemid 46020284)
7. O'Shea, R.; Moser, H. E. Physicochemical properties of antibacterial compounds: implications for drug discovery J. Med. Chem. 2008, 51, 2871-2878 (Pubitemid 351706014)
8. Leeson, P. D.; Davis, A. M. Time-related differences in the physical property profiles of oral drugs J. Med. Chem. 2004, 47, 6338-6348 (Pubitemid 39587257)
9. Miller, J. R.; Dunham, S.; Mochalkin, I.; Banotai, C.; Bowman, M.; Buist, S.; Dunkle, B.; Hanna, D.; Harwood, H. J.; Huband, M. D.; Karnovsky, A.; Kuhn, M.; Limberakis, C.; Liu, J. Y.; Mehrens, S.; Mueller, W. T.; Narasimhan, L.; Ogden, A.; Ohren, J.; Vara Prasad, J. V. N.; Shelly, J. A.; Skerlos, L.; Sulavik, M.; Thomas, V. H.; VanderRoest, S.; Wang, L.; Wang, Z.; Whitton, A.; Zhu, T.; Stover, C. K. A class of selective antibacterials derived from a protein kinase inhibitor pharmacophore Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 1737-1742
10. Gribble, F. M.; Loussouarn, G.; Tucker, S. J.; Zhao, C.; Nichols, C. G.; Ashcroft, F. M. A novel method for measurement of submembrane ATP concentration J. Biol. Chem. 2000, 275, 30046-30049
11. Imamura, H.; Huynh Nhat, K. P.; Togawa, H.; Saito, K.; Iino, R.; Kato-Yamada, Y.; Nagai, T.; Noji, H. Visualization of ATP levels inside single living cells with fluorescence resonance energy transfer-based genetically encoded indicators Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 15651-15656
12. Traut, T. W. Physiological concentrations of purines and pyrimidines Mol. Cell. Biol. 2004, 140, 1-22
13. Chapelle, E. W.; Levin, G. V. Use of the firefly bioluminescent reaction for rapid detection and counting of bacteria Biochem. Med. 1968, 2, 41-52
14. Cohen, P. Protein kinases: the major grug targets of the twenty-first century? Nat. Rev. Drug Discovery 2002, 1, 309-315 (Pubitemid 37361447)
15. Karaman, M. W.; Herrgard, S.; Treiber, D. K.; Gallant, P.; Atteridge, C. E.; Campbell, B. T.; Chan, K. W.; Ciceri, P.; Davis, M. I.; Edeen, P. T.; Faraoni, R.; Floyd, M.; Hunt, J. P.; Lockhart, D. J.; Milanov, Z. V.; Morrison, M. J.; Pallares, G.; Patel, H. K.; Pritchard, S.; Wodicka, L. M.; Zarrinkar, P. P. A quantitative analysis of kinase inhibitor selectivity Nat. Biotechnol. 2008, 26, 127-132
16. Bain, J.; Plater, L.; Elliott, M.; Shapiro, N.; Hastie, C. J.; McLauchlan, H.; Klevernic, I.; Arthur, J. S.; Alessi, D. R.; Cohen, P. The selectivity of protein kinase inhibitors: a further update Biochem. J. 2007, 408, 297-315
17. Silver, L. L. Multi-targeting by monotherapeutic antibacterials Nat. Rev. Drug Discovery 2007, 6, 41-55 (Pubitemid 46020285)
18. Wong, K. K.; Kuo, D. W.; Chabin, R. M.; Fournier, C.; Gregnas, L. D.; Waddell, S. T.; Marsilio, F.; Leiting, B.; Pompliano, D. L. Engeneering a cell-free murein biosynthetic pathway: Combinatorial enzymology in drug discovery J. Am. Chem. Soc. 1998, 120, 13527-13528 (Pubitemid 29025224)
19. Barreteau, H.; Kovač, A.; Boniface, A.; Sova, M.; Gobec, S.; Blanot, D. Cytoplasmic steps of peptydoglycan biosynthesis FEMS Microbiol. Rev. 2008, 32, 168-207
20. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. N.; Bourne, P. E. The Protein Data Bank Nucleic Acids Res. 2000, 28, 235-242 (Pubitemid 30047768)
21. http://www.pdb.org.
22. Overbye, K. M.; Barrett, J. F. Antibiotics: where did we go wrong? Drug Discovery Today 2005, 10, 45-52 (Pubitemid 40164818)
23. Newman, D. J.; Cragg, G. M.; Snader, K. M. The influence of natural products upon drug discovery Nat. Prod. Rep. 2000, 17, 251-234
24. Maxwell, A. DNA gyrase as a drug target Trends Microbiol. 1997, 5, 102-109 (Pubitemid 27139470)
25. Gellert, M.; O'Dea, M. H.; Itoh, T.; Tomizawa, J. Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase Proc. Natl. Acad. Sci. U.S.A. 1976, 73, 4474-4478 (Pubitemid 8013922)
26. Lewis, R. J.; Singh, O. M. P.; Smith, C. V.; Skarzynski, T.; Maxwell, A.; Wonacott, A. L.; Wigley, D. B. The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography EMBO J. 1996, 15, 1412-1420 (Pubitemid 26093794)
27. Wigley, D. B.; Davies, G. J.; Dodson, E. J.; Maxwell, A.; Dodson, G. Crystal structure of an N-terminal fragment of the DNA gyrase B protein Nature 1991, 351, 624-629 (Pubitemid 21896650)
28. Brino, L.; Urzhumtsev, A.; Mousli, M.; Bronner, C.; Mirschler, A.; Oudet, P.; Moras, D. Dimerization of Escherichia coli DNA-gyrase B provides a structural mechanism for activating the ATPase catalytic center J. Biol. Chem. 2000, 275, 9468-9475 (Pubitemid 30185175)
29. Lamour, V.; Hoermann, L.; Jeltsch, J.; Oudett, P.; Moras, D. An open conformation of Thermus thermophilus Gyrase B ATP-binding domain J. Biol. Chem. 2002, 277, 18947-18953 (Pubitemid 34952456)
30. Tsai, F. T. F.; Singh, O. M. P.; Skarzynski, T.; Wonacott, A. J.; Weston, S.; Tucker, A.; Pauptit, R. A.; Breeze, A. L.; Poyser, J. P.; O'Brien, R.; Ladbury, J. E.; Wigley, D. B. The high-resolution crystal structure of a 24-kDa Gyrase B fragment from E. coli complexed with one of the most potent coumarin inhibitors, clorobiocin Proteins 1997, 28, 41-52 (Pubitemid 27194017)
31. Holdgate, G. A.; Tunnicliffe, A.; Ward, W. H. J.; Weston, S. A.; Rosenbrock, G.; Barth, P. T.; Taylor, I. W. F.; Paupit, R. A.; Timms, D. The entropic penalty of ordered water accounts for weaker binding of the antibiotic novobiocin to a resistant mutant of DNA gyrase: a thermodynamic and crystallographic study Biochemistry 1997, 36, 9663-9673 (Pubitemid 27364677)
32. Maxwell, A.; Lawson, D. M. The ATP-binding site of type II topoisomerases as a target for antibacterial drugs Curr. Top. Med. Chem. 2003, 3, 283-303
33. Gilbert, E. J.; Maxwell, A. The 24-kDa N-terminal subdomain of the DNA gyrase B protein coumarin drugs Mol. Microbiol. 1994, 12, 365-373 (Pubitemid 24197493)
34. Stierand, K.; Maass, P.; Rarey, M. Molecular complexes at a glance: automated generation of two-dimensional complex diagrams Bioinformatics 2006, 22, 1710-1716 (Pubitemid 44288332)
35. PoseViewWeb is available at http://poseview.zbh.uni-hamburg.de/poseview.
36. Oblak, M.; Kotnik, M.; Šolmajer, T. Discovery and development of ATPase inhibitors of DNA gyrase as antibacterial agents Curr. Med. Chem. 2007, 14, 2033-204
37. Ferroud, D.; Collard, J.; Klich, M.; Dupuis-Hamelin, C.; Mauvais, P.; Lassaigne, P.; Bonnefoy, A.; Musicki, B. Synthesis and biological evaluation of coumarincarboxylic acids as inhibitors of gyrase B. L-rhamnose as an effective substitute for L-noviose Bioorg. Med. Chem. Lett. 1999, 9, 2881-2886 (Pubitemid 29481182)
38. Periers, A. M.; Laurin, P.; Ferroud, D.; Haesslein, J. L.; Klich, M.; Dupuis-Hamelin, C.; Mauvais, P.; Lassaigne, P.; Bonnefoy, A.; Musicki, B. Antimicrobial and DNA gyrase-inhibitory activities of novel clorobiocin derivatives produced by mutasynthesis Bioorg. Med. Chem. Lett. 2000, 10, 161-165
39. Musicki, B.; Periers, A. M.; Laurin, P.; Ferroud, D.; Benedetti, Y.; Lachaud, S.; Chatreaux, F.; Haesslein, J. L.; Iltis, A.; Pierre, C.; Khider, J.; Tessot, N.; Airault, M.; Demassey, J.; Dupuis-Hamelin, C.; Lassaigne, P.; Bonnefoy, A.; Vicat, P.; Klich, M. Improved antibacterial activities of coumarin antibiotics bearing 5′,5′-dialkylnoviose: biological activity of RU79115 Bioorg. Med. Chem. Lett. 2000, 10, 1695-1699 (Pubitemid 30495242)
40. Bellon, S.; Parsons, J. D.; Wei, Y.; Hayakawa, K.; Swonson, L. L.; Charifson, P. S.; Lippke, J. A.; Aldape, R.; Gross, C. H. Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase Antimicrob. Agents Chemother. 2004, 48, 1856-1864 (Pubitemid 38544398)
41. Plesniak, L. A.; Botsch, K.; Leibrand, M.; Kelly, M.; Sem, D.; Adams, J. A.; Jennings, P. Transferred NOE and saturation transfer difference NMR studies of novobiocin binding to EnvZ suggest binding mode similar to DNA gyrase Chem. Biol. Drug Des. 2008, 71, 28-35
42. Marcu, M. G.; Chadli, A.; Bouhoche, I.; Catelli, M.; Neckers, L. M. The heat shock protein 90 antagonist novobiocin interacts with a previously unrecognized ATP-binding domain in the carboxyl terminus of the chaperone J. Biol. Chem. 2000, 275, 37181-37186 (Pubitemid 32002137)
43. Dutta, R.; Inouye, M. GHKL, an emergent ATPase/kinase superfamily Trends Biochem. Sci. 2000, 25, 24-28 (Pubitemid 30060426)
44. Tanaka, T.; Saha, S. K.; Tomomori, C.; Ishima, R.; Liu, D.; Tong, K. I.; Park, H.; Dutta, R.; Qin, L.; Swindells, M. B.; Yamazaki, T.; Ono, A. M.; Kainosho, M.; Inouye, M.; Ikura, M. NMR structure of the histidine kinase domain of the E. coli osmosenzor EnvZ Nature 1998, 396, 88-92 (Pubitemid 28520455)
45. Nakada, N.; Gmünder, H.; Hirata, T.; Arisawa, M. Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor Antimicrob. Agents Chemother. 1994, 40, 473-476
46. Lewis, R. J.; Singh, O. M. P.; Smith, C. V.; Skarynski, T.; Maxwell, A.; Wonacott, A. J.; Wigley, D. B. The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography EMBO J. 1996, 15, 1412-1420 (Pubitemid 26093794)
47. Corbett, K. D.; Berger, J. M. Structural basis for topoisomerase VI inhibition by the anti-Hsp90 drug radicicol Nucleic Acids Res. 2006, 34, 4269-4277 (Pubitemid 44542206)
48. Besant, P. G.; Lasker, M. V.; Bui, C. D.; Turck, C. W. Inhibition of branched-chain α-keto acid dehydrogenase kinase and Sln1 yeast histidine kinase by the antifungal antibiotic radicicol Mol. Pharmacol. 2002, 62, 289-296 (Pubitemid 34804108)
49. Guarnieri, M. T.; Zhang, L.; Shen, J.; Zhao, R. The Hsp90 inhibitor radicolol interacts with the ATP-binding pocket of bacterial sensor kinase PhoQ J. Mol. Biol. 2008, 379, 82-93
50. Schulte, T. W.; Akinaga, S.; Murakata, T.; Agatsuma, T.; Sudimoto, S.; Nakano, H.; Lee, Y. S.; Simen, B. B.; Argon, Y.; Felts, S.; Toft, D. O.; Neckers, L. M.; Sharma, S. V. Interaction of radicicol with members of the heat shock protein 90 family of molecular chaperones Mol. Endocrinol. 1999, 13, 1435-1448 (Pubitemid 30650587)
51. Roe, S. M.; Prodromou, C.; O'Brien, R.; Ladbury, J. E.; Piper, P. W.; Pearl, L. H. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin J. Med. Chem. 1999, 42, 260-266 (Pubitemid 29069861)
52. Marina, A.; Mott, C.; Auyzenberg, A.; Hendrickson, W. A.; Waldburger, C. D. Structural and mutational analysis of the PhoQ histidine kinase catalytic domain. Insight into the reaction mechanism J. Biol. Chem. 2001, 276, 41182-41190
53. Silver, L. L. Are natural products still the best source for antibacterial discovery? The bacterial entry factor Expert Opin. Drug Discovery 2008, 3, 487-500 (Pubitemid 351771990)
54. Newman, D. J. Natural products as leads to potential drugs: an old process or the new hope for drug discovery? J. Med. Chem. 2008, 51, 2589-2599 (Pubitemid 351620778)
55. McGovern, S. L.; Shoichet, B. K. Kinase inhibitors: not just for kinases anymore J. Med. Chem. 2003, 46, 1478-1483 (Pubitemid 36512711)
56. Shaw, K. J.; Rather, P. N.; Hare, R. S.; Miller, G. H. Molecular genetics of aminoglycoside resistance genes and familiar relationships of the aminoglycoside-modifying enzymes Microbiol. Mol. Biol. Rev. 1993, 57, 138-163 (Pubitemid 23078440)
57. Daigle, D. M.; McKay, G. A.; Thompson, P. R.; Wright, G. D. Aminoglycoside antibiotic phosphotransferases are also serine protein kinases Chem. Biol. 1999, 6, 11-18 (Pubitemid 29363041)
58. Triola, G.; Wetzel, S.; Ellinger, B.; Koch, M. A.; Hübel, K.; Rauh, D.; Waldmann, H. ATP competitive inhibitors of d -alanine- d -alanine ligase based on protein kinase inhibitors scaffolds Bioorg. Med. Chem. 2009, 17, 1079-1087
59. Barreteau, H.; Kovač, A.; Boniface, A.; Sova, M.; Gobec, S.; Blanot, D. Cytoplasmic steps of peptidoglycan biosynthesis FEMS Microbiol. Rev. 2008, 32, 68-207
60. Al-Bar, O. A. M.; O'Connor, C. D.; Giles, I. G.; Akhtar, M. d -Alanine: d -alanine ligase of Escherichia coli. Expression, purification and inhibitory studies on the cloned enzyme Biochem. J. 1992, 282, 747-752
61. Waldrop, G. L.; Rayment, I.; Holden, H. M. Three-dimensional structure of biotin carboxylase subunit of acetyl-CoA carboxylase Biochemistry 1994, 33, 10249-10256 (Pubitemid 24281789)
62. Mochalkin, I.; Miller, J. R.; Narasimhan, L.; Thanabal, V.; Erdman, P.; Cox, P. B.; Vara Prasad, J. V. N.; Lightle, S.; Hunband, M. D.; Kendall Stover, C. Discovery of antibacterial biotin carboxylase inhibitors by virtual screening and fragment-based approaches ACS Chem. Biol. 2009, 4, 472-483
63. Mochalkin, I.; Miller, J. R.; Evdokimov, A.; Lightle, S.; Yan, C.; Stover, C. K.; Waldrop, G. L. Structural evidence for substrate-induced synergism and half-sites reactivity in biotin carboxylase Protein Sci. 2008, 17, 1706-1718
64. Hung, A. W.; Silvestre, L.; Wen, S.; Ciulli, A.; Blundell, T. L.; Abell, C. Application of fragment growing and fragment linking to the discovery of inhibitors of Mycobacterium tuberculosis pantothenate synthetase Angew. Chem., Int. Ed. 2009, 48, 8452-8456
65. Wang, S.; Eisenberg, D. Crystal structures of a pantothenate synthetase from M. tuberculosis and its complexes with substrates and a reaction intermediate Protein Sci. 2003, 12, 1097-1108 (Pubitemid 36505443)
66. Velaparthi, S.; Brunsteiner, M.; Uddin, R.; Wan, B.; Franzblau, S. G.; Petukhov, P. A. 5- tert -Butyl- N -pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[ d ]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs J. Med. Chem. 2008, 51, 1999-2002 (Pubitemid 351503254)
67. Fan, C.; Park, I. S.; Walsh, C. T.; Knox, J. R. d -Alanine: d -alanine ligase: phosphonate and phosphinate intermediates with wild type and the Y216F mutant Biochemistry 1997, 36, 2531-2538 (Pubitemid 27106645)
68. Kovač, A.; Konc, J.; Vehar, B.; Bostock, J. M.; Chopra, I.; Janežič, D.; Gobec, S. Discovery of new inhibitors of d -alanine: d -alanine ligase by structure-based virtual screening J. Med. Chem. 2008, 52, 7442-7448
69. Boehm, H. J.; Boehringer, M.; Bur, D.; Gmuender, H.; Huber, W.; Klaus, W.; Kostrewa, D.; Kuehne, H.; Luebbers, T.; Meunier-Keller, N.; Mueller, F. Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alernative to random screening J. Med. Chem. 2000, 43, 2664-2674 (Pubitemid 30463915)
70. Cheng, C. C.; Shipps, G. W., Jr.; Yang, Z.; Sun, B.; Kawahata, N.; Soucy, K. A.; Soriano, A.; Orth, P.; Xiao, L.; Mann, P.; Black, T. Discovery and optimization of antibacterial AccC inhibitors Bioorg. Med. Chem. Lett. 2009, 19, 6507-6514
71. Congreve, M.; Chessari, G.; Tisi, D.; Woodhead, A. J. Recent developments in fragment-based drug discovery J. Med. Chem. 2008, 51, 3661-3680 (Pubitemid 351956496)
72. Sledz, P.; Silvestre, L.; Hung, A. W.; Ciulli, A.; Blundell, T. L.; Abell, C. Optimization of the interligand Overhauser effect for fragment linking: application to inhibitor discovery against Mycobacterium tuberculosis pantothenate synthetase J. Am. Chem. Soc. 2010, 132, 4544-4545
73. Csermely, P.; Ágoston, V.; Pongor, S. The efficiency of multi-target drugs: the network approach may help drug design Trends Pharmacol. Sci. 2005, 26, 178-182 (Pubitemid 40432652)
74. Charifson, P. S.; Grillot, A.; Grossman, T. H.; Parsons, J. D.; Badia, M.; Bellon, S.; Deininger, D. D.; Drumm, J. E.; Gross, C. H.; Le Tiran, A.; Liao, Y.; Mani, N.; Nicolau, D. P.; Perola, E.; Ronkin, S.; Shannon, D.; Swenson, L. L.; Tang, Q.; Tessier, P. R.; Tian, S.; Trudeau, M.; Wang, T.; Wei, Y.; Zhang, H.; Stamos, D. Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships J. Med. Chem. 2008, 51, 5243-5263
75. Burk, D. L.; Hon, W. C.; Leung, A. K.-W; Berghuis, A. M. Structural analyses of nucleotide binding to an aminoglycoside phosphotransferase Biochemistry 2001, 40, 8756-8764 (Pubitemid 32709507)
76. Boehr, D. D.; Farley, A. R.; Wright, G. D.; Cox, J. R. Analysis of the π-π stacking interactions between the aminoglycoside antibiotic kinase APH(3′)-IIIa and its nucleotide ligands Chem. Biol. 2002, 9, 1209-1217 (Pubitemid 35348274)
77. Boehr, D. D.; Farley, A. R.; LaRonde, F. J.; Murdock, T. R.; Wright, G. D.; Cox, J. R. Establishing the principles of recognition in the adenine-binding region of an aminoglycoside antibiotic kinase [APH(3′)-IIIa] Biochemistry 2005, 44, 12445-12453 (Pubitemid 41324336)
78. Wang, S.; Eisenberg, D. Crystal structure of the pantothenate synthetase from Mycobacterium tuberculosis, snapshots of the enzyme in action Biochemistry 2006, 45, 1554-1561 (Pubitemid 43222099)
79. Williams, L.; Zheng, R.; Blanchard, J. S.; Raushel, F. M. Positional isotope exchange analysis of the pantothenate synthetase reaction Biochemistry 2003, 42, 5108-5113 (Pubitemid 36532065)
80. Tuck, K. L.; Saldanha, S. A.; Birch, L. M.; Smith, A. G.; Abell, C. The design and synthesis of inhibitors of pantothenate synthetase Org. Biomol. Chem. 2006, 4, 3598-3610 (Pubitemid 44439880)
81. Ciulli, A.; Scott, D. E.; Ando, M.; Reyes, F.; Saldanha, S. A.; Tuck, K. L.; Chirgadze, D. Y.; Blundel, T. L.; Abell, C. Inhibition of Mycobacterium tuberculosis pantothenate synthetase by analogues of the reaction intermediate ChemBioChem 2008, 9, 2606-2611
82. Scott, D. E.; Dawes, G. J.; Ando, M.; Abell, C.; Ciulli, A. A fragment-based approach to probing adenosine recognition sites by using dynamic combinatorial chemistry ChemBioChem 2009, 10, 2772-2779
83. Konc, J.; Janezic, D. ProBiS algorithm for detection of structurally similar protein binding sites by local structural alignment Bioinformatics 2010, 26, 1160-1168
84. Konc, J.; Janezic, D. ProBiS: a Web server for detection of structurally similar protein binding sites Nucleic Acids Res. 2010, 38, 436-440
85. 50) of an enzymatic reaction Biochem. Pharmacol. 1973, 22, 3099-3108
86. Knight, Z. A.; Shokat, K. M. Features of selective kinase inhibitors Chem. Biol. 2005, 12, 621-637 (Pubitemid 43142039)